Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mitsuoka, T (1969). Vergleichende Untersuchungen über die Laktobazillen aus den Faeces von Menschen, Schweinen und Hühnern. Zbl. Bakt. Parasit. 210.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces, and human gastric mucosa
DNA G+C(%): 44.9
|
Lower T(℃): 25(+)
High T(℃): 45(+)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
ampicillin: S(MIC50): 0.5, MIC90: 2, RNG: (0.06–4)
amp-sulb: S(MIC50): 0.5, MIC90: 2, RNG: (0.06–4)
piper-taz: S(MIC50): 1, MIC90: 4, RNG: (0.06–16)
imipenem: S(MIC50): 0.25, MIC90: 2, RNG: (0.25–4)
|
cefoxitin: R(MIC50): >32, MIC90: >32, RNG: (0.25–>32)
|
|
fidaxomicin: R(MIC50): 8, MIC90: >32, RNG: (0.015->32)
|
moxifloxacin: S(MIC50): 0.25, MIC90: 1, RNG: (0.125–8)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
|
vancomycin: R(MIC50): >64, MIC90: >64, RNG: (0.25–>64)
|
|
metronidazole: R(MIC50): >64, MIC90: >64, RNG: (0.125–>64)
|
clindamycin: S(MIC50): 0.125, MIC90: 2, RNG: (0.06–4)
|